PopPK Profile of Qishe Pill: Study Protocol for a Phase I Clinical Trial

Status Recruiting

Clinical Trial Summary

Qishe Pill (Shanghai Sundise Traditional Chinese Medicine Co., Ltd, China), composed of processed Radix Astragali, Muscone, Szechuan Lovage Rhizome, Radix Stephaniae Tetrandrae, Ovientvine, and Calculus Bovis Artifactus, has been developed and spread in use into clinical settings in 2009. As individualization has become the trend of modern medicine, a personalized medicine of Qishe Pill should be documented and practiced with various patients according to the ancient TCM system, a classification of personalized constitution type, which has been established to determine predisposition and prognosis to diseases as well as therapy and life-style administration. Therefore, we describe the population pharmacokinetic profile of Qishe Pill and compare its extent of metabolism in the 3 major Constitution Type (Qi-Deficiency, Yin-Deficiency and Blood-Stasis) to address major challenges of individualized and standardized Traditional Chinese Medicine into clinical practice.

Clinical Trial Description

With the greatly increased morbidity of neck pain, it brought a large challenge to some optimal therapies for various situations in population at a given time based on their demographic, physiological and pathological characteristics. Chinese proprietary herbal medicines, as a kind of Complementary and Alternative Medicine (CAM), are usually developed from some well-established and long-standing recipes and formulated as tablets or capsules for commerce, convenience or palatability. Although these advantage mentioned, a good quantification and a strict standardization in detail are still need to be improved for individualized implementation in therapeutic strategies. Based on the YQHY decoction (Yi-Qi Hua-Yu Decoction, tonify Qi and promoting circulation and removing stasis), Qishe Pill (Shanghai Sundise Traditional Chinese Medicine Co., Ltd, China) has been developed and spread in use into clinical settings in 2009. As individualization has become the trend of modern medicine, a personalized medicine of Qishe Pill should be documented and practiced with various patients according to the ancient TCM system, a classification of personalized constitution type, which has been established to determine predisposition and prognosis to diseases as well as therapy and life-style administration. Therefore, we describe the population pharmacokinetic profile of Qishe Pill and compare its extent of metabolism in the 3 major Constitution Type (Qi-Deficiency, Yin-Deficiency and Blood-Stasis) to address major challenges of individualized and standardized Traditional Chinese Medicine into clinical practice. ;

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02294448
Study type	Interventional
Source	Shanghai University of Traditional Chinese Medicine
Contact	Xue-Jun Cui, Dr.
Email	13917715524@139.com
Status	Recruiting
Phase	Phase 1
Start date	November 2014
Completion date	July 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02906306` - Effects of Individual and Group Occupational Therapy on General Self-Efficacy, Psychological Well-Being, Personal Independence and Occupational Therapy in Older Adults	N/A
Completed	`NCT02478021` - Effects of Hydrocortisone on Social Cognition and Memory	N/A
Completed	`NCT01699893` - Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards Personalized Medicine	N/A
Completed	`NCT03905993` - Milieu Intérieur Collection - Genetic & Environmental Determinants Of Immune Phenotype Variance
Terminated	`NCT02296359` - Vaccination Response in Individual Monozygotic Twins	N/A
Terminated	`NCT02654704` - Vaccination Responses in Young and Older Adults
Recruiting	`NCT05201534` - Interventions in Mathematics and Cognitive Skills	N/A
Completed	`NCT02478034` - Effects of Mineralocorticoid Receptor Stimulation on Cognition	N/A
Completed	`NCT02102191` - Acute Physiological Effects of Electronic Sigarette vs Cigarette Smoking	N/A
Completed	`NCT02071485` - Non-Invasive Brain-Computer Interface for Virtual Object Control	N/A
Recruiting	`NCT03147443` - Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials	Phase 4
Completed	`NCT01748071` - The Realtime Detection for Individual Variation of Analgesic ：A Comparison of Sufentanil vs Fentanyl	N/A
Completed	`NCT02070614` - Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption	N/A
Recruiting	`NCT04601792` - A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method	Phase 4
Completed	`NCT02768636` - Can Omega-3 Improve Heart Rate Variability Measurement?	Phase 4
Completed	`NCT02761031` - Perioperative Heart Rate Variability Analysis in Realtime
Completed	`NCT01868152` - The Realtime Detection for Prediction of Opioid Analgesic	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.